Given the long-standing association between tauopathy and granulovacuolar degeneration, we sought to determine whether the presence of endogenous tau was a requirement for the formation of GVBs in vivo following application of α-synuclein PFFs. The gene discussed is MAPT; the disease is tauopathy.